Endometrial pattern in patients with primary hypoestrogenic amenorrhea receiving estrogen replacement therapy

Obstetrics and Gynecology

Volumn 56, Issue 3, 1980, Pages 349-355

  van Campenhout, Jacques ^a   Choquette, Pierre ^a   Vauclair, René ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; DIETHYLSTILBESTROL; DIMETHISTERONE; ESTROGEN; ESTRONE; ETHINYLESTRADIOL; ETHISTERONE; MEDROXYPROGESTERONE; MESTRANOL; NORETHISTERONE; NORETYNODREL; NORGESTREL; PROGESTERONE;

AMENORRHEA; DOSE RESPONSE; DRUG RESPONSE; DRUG THERAPY; ENDOCRINE SYSTEM; ENDOMETRIUM; ESTROGEN BLOOD LEVEL; FEMALE GENITAL SYSTEM; HISTOLOGY; HYPOESTROGENISM; MAJOR CLINICAL STUDY; PRIMARY AMENORRHEA; THERAPY;

ADULT; AMENORRHEA; BIOPSY; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ENDOMETRIAL HYPERPLASIA; ENDOMETRIUM; ESTROGENS; FEMALE; GONADAL DYSGENESIS; GONADOTROPINS; HUMAN; OVARIAN DISEASES; PROGESTATIONAL HORMONES; SYNDROME;

EID: 0018827182     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Aksel S, Wentz AC, Jones GS: Anovulatory infertility associated with adenocarcinoma and adenomatous hyperplasia of the endometrium. Obstet Gynecol 43:386, 1974
2. Fechner RE, Kaufman RH: Endometrial adenocarcinoma in Stein-Leventhal syndrome. Cancer 34:444, 1974
3. Wood GP, Boronow RC: Endometrial adenocarcinoma and the polycystic ovary syndrome. Am J Obstet Gynecol 124:140,1976
4. Jackson RL, Dockerty MB: The Stein-Leventhal syndrome: Analysis of 43 cases with special reference to association with endometrial carcinoma. Am J Obstet Gynecol 73:161, 1957
5. Audet-Lapointe P, Vauclair R: Les tumeurs de la granulosa. Union Med Can 96:975, 1967
6. Smith DC, Prentice R, Thompson DJ, et al: Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 293: 1164, 1975
7. Ziel HK, Finkle WD: Association of estrone with the development of endometrial carcinoma. Am J Obstet Gynecol 124:735, 1976
8. Ziel HK, Finkle WD: Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 293:1167, 1975
9. Smith DC, Prentice R, Thompson DJ, et al: Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 293: 1164, 1975
10. Mack TM, Pike MC, Henderson BE, et al: Estrogens and endometrial cancer in a retirement community. N Engl J Med 294: 1262, 1976
11. McDonald TW, Annegers JF, O'Fallon WM, et al: Exogenous estrogen and endometrial carcinoma; case-control and incidence study. Am J Obstet Gynecol 127:572, 1977
12. Dunn LJ, Bradbury JT: Endocrine factors in endometrial carcinoma: A preliminary report. Am J Obstet Gynecol 97:465,1967
13. Buchma MJ, Kramer E, Feldman G: Aspiration curettage for asymptomatic patients receiving estrogen. Obstet Gynecol 51: 339, 1978
14. Cohen CJ, Deppe G: Endometrial carcinoma and oral contraceptive agents. Obstet Gynecol 49:390, 1977
15. Kaufman RH, Reeves KO, Dougherty CM: Severe atypical endometrial changes and sequential contraceptive use. JAMA 236: 923, 1976
16. Kelley HW, Miles PA, Buster JE, et al: Adenocarcinoma of the endometrium in women taking sequential oral contraceptives. Obstet Gynecol 47:200, 1976
17. Kreuter A Jr, Johnson D, Williamson HO: Histology of the endometrium in long-term use of a sequential oral contraceptive. Fertil Steril 27:905, 1976
18. Lyon FA: The development of adenocarcinoma of the endometrium in young women receiving long-term sequential oral contraception: Report of four cases. Am J Obstet Gynecol 123:299, 1975
19. Silverberg SG, Makowski EL: Endometrial carcinoma in young women taking oral contraceptives. Obstet Gynecol 46:503,1975
20. Silverberg SG, Makowski EL, Roche WD: Endometrial carcinoma in women under 40 years of age: Comparison of cases in oral contraceptive users and non-users. Cancer 39:592, 1977
21. Dowsett JW: Corpus carcinoma developing in a patient with Turner's syndrome treated with estrogen. Am J Obstet Gynecol 86:622, 1963
22. Roberts G, Wells AL: Oestrogen-induced endometrial carcinoma in a patient with gonadal dysgenesis. Br J Obstet Gynaecol 82:417, 1975
23. McCarroll AM, Montgomery DAD, Harley JMG, et al: Endometrial carcinoma after cyclical estrogen-progestogen therapy for Turner's syndrome. Br J Obstet Gynaecol 82:421, 1975
24. Canlorbe P, Chartier M, Vink LT: Probable uterine cancer after prolonged treatment of Turner's syndrome with estrogen. Ann Pediatr (Paris) 14:323, 1967
25. Wilkinson EJ, Friedrich EG, Mattingly RF, et al: Turner's syndrome with endometrial adenocarcinoma and stilbestrol therapy. Obstet Gynecol 42:193, 1973
26. Cutler BS, Forbes AP, Ingersol FM, et al: Endometrial carcinoma after stilbestrol therapy in gonadal dysgenesis. N Engl J Med 287:628, 1972
27. Scott T: Turner's syndrome and vermiform phlebectasia of the bowel. Trans Am Clin Climatol Assoc 79:45, 1967
28. Sirota DK, Marinoff SC: Endometrial carcinoma in Turner's syndrome following prolonged treatment with diethylstilbestrol. Mt Sinai J Med NY 42:586, 1975
29. Krishnamurthy S, Adcock LL, Okagaki T: Endometrial carcinoma following estrogen-progestogen therapy in Turner's syndrome. A case report and review of the literature. Gynecol Oncol 5:291, 1977
30. Louka MH, Lee JH, Lewis GC: Endometrial carcinoma in Turner's syndrome. Gynecol Oncol 6:294, 1978
31. Ostor AG, Fortune DW, Evans JH, et al: Endometrial carcinoma in gonadal dysgenesis with and without estrogen therapy. Gynecol Oncol 6:316, 1978
32. Rosenwaks Z, Wentz AC, Jones GS, et al: Endometrial pathology and estrogens. Obstet Gynecol 53:403, 1979
33. Hammond CB, Jelovsek FR, Lee KL, et al: Effects of long term estrogen therapy. Neoplasia. Am J Obstet Gynecol 133:537, 1979
34. Benjamin I, Block RE: Endometrial response to estrogen and progesterone therapy in patients with gonadal dysgenesis. Obstet Gynecol 50:136, 1977
35. Dewhurst CJ, De Koos EB, Haines RM: Replacement hormone therapy in gonadal dysgenesis. Br J Obstet Gynaecol 82:412, 1975
36. Gray PH, Anderson CT, Munnell EW: Endometrial adenocarcinoma and ovarian agenesis. Report of a case. Obstet Gynecol 35:513, 1970
37. Lewis FJW, Mitchell JP, Foss GL: XY/XO mosaicism. Lancet 1: 221, 1963
38. Lauritzen C: The management of the premenopausal and the postmenopausal patient. Front Horm Res 2:2, 1973
39. Ferin J: Effect of replacement therapy on endometrium in postmenopausal women, The Menopausal Syndrome. Edited by RB Greenblatt, VB Mahesh, P McDonough. Berkeley, CA, Med-com Press, 1974, pp 143-147
40. Henzl MR, Moyer DL, Towsend D, et al: Quantitation of the estrogenic effects of mestranol on human endometrium and vaginal mucosa. Am J Obstet Gynecol 115:401, 1973
41. Vanderick G, Beernaert J, De Muylder E, et al: Hormonal contraception. Sequential formulations and the endometrium. Contraception 12:655, 1975
42. Sturdee DW, Wade-Evan T, Paterson M, et al: Relations between bleeding pattern, endometrial histology and oestrogen treatment in menopausal women. Br Med J 1:1575, 1978
43. Lauritzen C: Oestrogens and endometrial cancer, a point of view. Clin Obstet Gynecol 4:145, 1977